Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
05/24/18 8-K Current report filing
Related Documents
8
05/17/18 424B3 Prospectus filed pursuant to Rule 424(b)(3) 38
05/16/18 EFFECT Notice of Effectiveness 1
05/14/18 CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission. 2
05/14/18 8-K Current report filing
Related Documents
7
05/11/18 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
27
05/09/18 UPLOAD SEC-generated letter 1
05/01/18 8-K Current report filing 3
05/01/18 S-3 Registration statement for specified transactions by certain issuers
Related Documents
129
04/19/18 DEF 14A Definitive proxy statements 84